INSL3 insulin-like 3
Selected indexed studies
- Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold. (Aging Male, 2024) [PMID:38676285]
- Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology. (Hum Reprod Update, 2018) [PMID:30204868]
- Diverse functions of insulin-like 3 peptide. (J Endocrinol, 2020) [PMID:32813485]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold. (2024) pubmed
- Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology. (2018) pubmed
- Diverse functions of insulin-like 3 peptide. (2020) pubmed
- Insulin-Like Peptide 3 (INSL3) Serum Concentration During Human Male Fetal Life. (2019) pubmed
- Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men. (2022) pubmed
- Cryptorchidism and Hypospadias. (2000) pubmed
- Insulin-like peptide 3 in domestic animals with normal and abnormal reproductive functions, in comparison to rodents and humans. (2022) pubmed
- Insulin-like 3 affects zebrafish spermatogenic cells directly and via Sertoli cells. (2021) pubmed
- Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency. (2024) pubmed
- Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression. (2023) pubmed